COMPANY PROFILE
Immutep GmbH
GmbH (Limited Liability Company)BerlinResearch and experimental development on biotechnology
FOUNDED
2011
15+ years active
TRADE REGISTER
HRB 257943
Berlin (Charlottenburg)
INDUSTRY
Research and experimental development on biotechnology
SIZE CLASS
Medium-sized enterprise
Key questions answered
What does the company do?
Forschung, Entwicklung und Kommerzialisierung von neuartigen Medikamenten und Therapien, sowie sämtliche erlaubte Aktivitäten die für den Geschäftszweck erforderlich oder dienlich sind.
Who leads it?
Deanne Miller, Marc Voigt
How large is it?
Medium-sized enterprise · 21 employees (2023)
How stable is it?
Stability assessment in Plus profile
Business activity
Industry (WZ2008)
Research and experimental development on biotechnology
WZ M72.11
Size class
Medium
Industry (WZ2008) (3)
- M72.11Research and experimental development on biotechnology
- M72.19Other research and experimental development on natural sciences and engineering
- M74.90Other professional, scientific and technical activities n.e.c.
Business purpose
Forschung, Entwicklung und Kommerzialisierung von neuartigen Medikamenten und Therapien, sowie sämtliche erlaubte Aktivitäten die für den Geschäftszweck erforderlich oder dienlich sind.
Legal essentials
- Register entry
- HRB 257943 (Berlin (Charlottenburg))
- Legal form
- GmbH (Limited Liability Company)
- Founded
- 03 May 2011
- Share capital
- €16,525,000
- VAT ID
- —
- LEI
- 529900HRSA447K1XAD50
- Representation rules
- Ist ein Geschäftsführer bestellt, so vertritt er die Gesellschaft allein. Sind mehrere Geschäftsführer bestellt, wird die Gesellschaft gemeinschaftlich durch zwei Geschäftsführer oder durch einen Geschäftsführer in Gemeinschaft mit einem Prokuristen vertreten.
Order shareholder list
The statutory shareholder list (§ 40 GmbHG) straight from the official register portal — who holds which shares.
Available once you sign in
Annual statements
- Balance sheet
- €42,359,856
- Year
- 2023
10 annual statements are on file for this company.
Signals
Four dimensions from hard data — age, financials, HRB events, compliance. The ratings themselves are shown in the Plus profile only.
- Continuity1Available in Plus profile
- Financials2Available in Plus profile
- Management3Available in Plus profile
- Legal status4Available in Plus profile
Directors & officers
Managing directors
Deanne Miller
Managing Director
Marc Voigt
Managing Director
Research contacts
AI-powered research for publicly available contacts: name, role, phone, email, LinkedIn.
Available once you sign in
Recent news
AI-powered research across press, social media and job postings from the last six months.
Available once you sign in
Commercial register history
No events on file.
Companies with a similar profile
MetaImmune Therapeutics GmbH
Berlin
Immunentech GmbH
Mainz
Pharmilabs UG (haftungsbeschränkt)
Potsdam
Medpace Germany GmbH
München
Epimune GmbH
Berlin
Optimapharm Deutschland GmbH
Germering
TissueImmune Therapeutics GmbH
Möhrendorf
IMP Institut für Medizin und Pharmazie GmbH
Berlin
KànMedIm UG (haftungsbeschränkt)
Steinfurt
ProMedeus Immuntechnologie GmbH
Offenbach am Main
Location neighbours
DEVELOPERS
Programmatic access
Three ways to access this company's data programmatically:
- AGENT-CARD
Freely accessible, no API key required — a compact JSON summary for agents and crawlers.
- API
Full, authenticated data via the Implisense API v2 (API key required).
- MCP
MCP server live at mcp.implisense.com (FastMCP, Bearer auth) — usable with ChatGPT, Claude, and your own agents.
What the Plus profile adds
The same page, fully populated — plus the research services locked here.
- Revenue, result and equity across every available year
- All four signals with rationale and source
- Contact search: names, roles, phone, email, LinkedIn
- Shareholder list from the official register portal
- News research covering the last six months
- The full commercial register history